Related Experiment Video
Updated: Oct 2, 2026

A Pre-Clinical Model of Synovitis Using Ex vivo Human Synovial Tissue with Preserved Function and Architecture
Published on: March 20, 2026
Synvisc perisynovitis
1Mayne Health, Laverty Pathology, Newcastle Laboratory, NSW, Australia. zardawi@hotmail.com
Abstract:
Synvisc (hylan G-F 20) is a high molecular weight hyaluronan which is manufactured from chicken combs. It is currently one of the options used in the treatment of severe osteoarthritis of the knee joint. Synvisc is directly injected into the diseased joint, where it provides elasticity and viscosity. Published experience suggests than Synvisc is a safe and well-tolerated material with occasional mild local reactions but no long-term adverse sequelae. This article describes a case of Synvisc-related granulomatous inflammation in the perisynovial adipose tissue. To our knowledge, this is the first histological account of tissue reaction to Synvisc.
Related Concept Videos
Pericarditis I: Introduction
Pericarditis III: Medical Management
Pericarditis IV: Nursing Management
Acute Inflammation III: Local and Systemic Effects
Vascular Spasm
Nephrotic Syndrome I : Introduction